Startups
Orphan Star Therapeutics is committed to bringing hope to life for children with rare diseases by expediting the development of new therapies with innovation, ingenuity and insight.
Overview
Employees
11-50
Total raised
$20M
Founded date
2018
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 26, 2018 | Orphan Star Therapeutics Secures $20M Commitment | Orphan Star Therapeutics, a NYC-based biopharmaceutical company focused on developing innovative therapies for rare diseases, secured a commitment of $20m from an unnamed commercial pharmaceutical partner. The company intends to use the fun... |
Reviews 0
FAQ about Orphan Star Therapeutics
When was Orphan Star Therapeutics founded?
Orphan Star Therapeutics was founded in 2018.
How much funding has Orphan Star Therapeutics raised?
Orphan Star Therapeutics has raised $20M in total across 1 funding round.
What has the press written about Orphan Star Therapeutics?
Parsers VC has collected 2 articles mentioning Orphan Star Therapeutics, among them “Orphan Star Therapeutics Secures $20M Commitment” (Sep 26, 2018).
Is Orphan Star Therapeutics still active?
Yes, Orphan Star Therapeutics is active; its latest activity on Parsers VC dates from May 7, 2021.